medicationPrescription only (US)Oral isotretinoin (Accutane and generics) is FDA-approved for severe recalcitrant nodular acne and is dispensed only through the iPLEDGE risk-management program because of teratogenicity
IsotretinoinBenefits, Dosage & Interactions
Also known as: Accutane
Isotretinoin is an oral retinoid medication primarily used for severe, recalcitrant nodular acne that has not responded to other treatments, including oral antibiotics. It is typically taken with a meal. The reported plasma half-life is about 10 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial and regulatory approval on file.
Plasma half-life
10–20 h
Typical timing
with meal
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The Cochrane review's included dose-comparison trials studied continuous low-dose (0.25–0.4 mg/kg/day), continuous conventional-dose (0.5–1 mg/kg/day), and intermittent (one week per month) oral isotretinoin regimens; the antihistamine-adjuvant trial dosed isotretinoin without specifying a fixed mg/kg figure in the abstract[1][2]
Reported for Isotretinoin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Isotretinoin entry is written from. Each number matches an inline marker above.
- [1]Oral isotretinoin for acneCosta CS, Bagatin E, Martimbianco ALC, da Silva EM, Lúcio MM, Magin P, Riera R · Cochrane Database of Systematic Reviews · 2018 · Peer-reviewed · PMID 30484286
- [2]Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative studyLee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M · Journal of the European Academy of Dermatology and Venereology · 2014 · Peer-reviewed · PMID 25081735
How to track Isotretinoin doses
Tracking Isotretinoin well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Isotretinoin with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is with_meal. Take it with food, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Isotretinoin through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 10 h, effects and timing shifts show up over days rather than instantly. Review Isotretinoin alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day and whether it was taken with food
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Isotretinoin dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Isotretinoin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Isotretinoin is an oral retinoid medication primarily used for severe, recalcitrant nodular acne that has not responded to other treatments, including oral antibiotics. It is derived from vitamin A and works by significantly reducing the size and activity of sebaceous glands, thereby decreasing sebum production (NIH ODS). Isotretinoin also has anti-inflammatory properties and helps normalize follicular keratinization, preventing the formation of comedones. Due to its potent effects and significant potential for adverse effects, isotretinoin is a highly regulated medication and requires strict monitoring by a healthcare professional. It is available under various brand names, though Accutane, one of the original brands, has been discontinued (FDA label).
What does the research say about Isotretinoin?
Tap a section to expand.
Isotretinoin's primary mechanism of action involves reducing the size and activity of sebaceous glands, leading to a substantial decrease in sebum production. Sebum is an oily substance produced by the skin's glands, and its overproduction is a key factor in the development of acne. By reducing sebum, isotretinoin creates an environment less conducive to the growth of *Propionibacterium acnes* (now known as *Cutibacterium acnes*), a bacterium implicated in acne (PubChem). Beyond its effect on sebum, isotretinoin also modifies follicular keratinization, meaning it helps normalize the shedding of skin cells within hair follicles, which prevents them from becoming clogged and forming comedones (blackheads and whiteheads). Additionally, it possesses anti-inflammatory properties that reduce the redness and swelling associated with acne lesions (DrugBank). The exact molecular pathways involved are complex but include interaction with retinoid acid receptors in cells.
Source for this section: Sources for How does Isotretinoin work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefit of isotretinoin is its effectiveness in treating severe, recalcitrant nodular acne. For individuals with severe acne that has not responded to other therapies, isotretinoin can lead to substantial and often long-lasting improvement or complete clearance of acne lesions (Cochrane, 2018 review). It significantly reduces the number and severity of inflammatory lesions (papules, pustules, cysts, and nodules) and non-inflammatory lesions (comedones). Beyond the physical improvement in skin appearance, successful treatment with isotretinoin can lead to significant psychosocial benefits, including improved self-esteem, reduced anxiety, and a better quality of life for individuals severely affected by acne (Mayo Clinic). Its long-term efficacy often means that patients do not require further acne treatment after completing a course.
Numerous studies and clinical reviews support the efficacy of isotretinoin for severe acne. A Cochrane review published in 2018, which analyzed several randomized controlled trials, concluded that isotretinoin is an effective treatment for severe acne, often leading to complete or near-complete remission. The review highlighted its superior efficacy compared to oral antibiotics or topical treatments for severe cases. The FDA label for isotretinoin details its approval based on clinical trials demonstrating significant reductions in inflammatory nodule counts. Long-term follow-up studies, such as those referenced by the American Academy of Dermatology, confirm the sustained benefits in many patients after completing a course of isotretinoin, with a significant number experiencing prolonged remission. Evidence consistently shows that a complete course of isotretinoin at an appropriate cumulative dose provides the best chances of long-term clearance (NIH ODS).
Isotretinoin is associated with a range of side effects, many of which are dose-dependent. Common side effects include dry skin, chapped lips (cheilitis), dry eyes, dry mouth, and nosebleeds. Musculoskeletal symptoms such as joint pain and back pain can occur. Some individuals may experience hair thinning, sun sensitivity, and changes in mood. Rare but serious side effects include elevated liver enzymes, increased cholesterol and triglyceride levels, and inflammatory bowel disease. Blood tests are typically performed before and during treatment to monitor for these effects. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Isotretinoin carries several serious warnings. The most significant is its severe teratogenicity, meaning it can cause severe birth defects if taken during pregnancy. Therefore, it is absolutely contraindicated in pregnant women, and strict pregnancy prevention programs (like iPLEDGE in the U.S.) are mandatory for all female patients of childbearing potential. These programs require multiple negative pregnancy tests before, during, and after treatment, and the use of two forms of contraception. There is also a warning regarding potential psychiatric effects, including depression, mood disturbance, psychosis, and, rarely, suicidal ideation. Patients should be monitored for new or worsening psychiatric symptoms. Other warnings include potential for severe skin reactions, increased intracranial pressure, visual disturbances, and hearing impairment. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Isotretinoin is strictly contraindicated in pregnant women and women who may become pregnant unless all conditions of a pregnancy prevention program are met. It is also contraindicated in individuals with hypersensitivity to isotretinoin or any of its excipients. Patients with severe hepatic impairment, uncontrolled hyperlipidemia, or hypervitaminosis A should not take isotretinoin. Concurrent use of tetracyclines is also a contraindication due to the risk of increased intracranial pressure. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Isotretinoin should not be mixed with several other medications or substances. It is critically important to avoid concomitant use with tetracycline antibiotics (e.g., doxycycline, minocycline) due to the risk of pseudotumor cerebri (benign intracranial hypertension). Vitamin A supplements should be avoided, as isotretinoin is a derivative of vitamin A, and excessive intake could lead to hypervitaminosis A. Other retinoid medications (topical or oral) should also be avoided to prevent additive toxicity. Alcohol consumption should be limited or avoided during treatment due to the potential for increased liver enzyme elevation. St. John's Wort should be avoided as it may decrease the effectiveness of hormonal contraception, which is crucial for female patients on isotretinoin. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Isotretinoin is typically taken orally once or twice daily. It is crucial to take isotretinoin with a meal, as food (particularly fatty meals) significantly increases its absorption, ensuring optimal efficacy. The exact dosage and duration of treatment are user-directed and must be set by a licensed clinician based on factors such as body weight, response to treatment, and the severity of acne. A typical course of treatment lasts for several months, often 15 to 20 weeks, to achieve a cumulative dose that maximizes efficacy and minimizes relapse rates.
Source for this section: Sources for When should you take Isotretinoin?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Isotretinoin?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
Frequently asked questions about Isotretinoin
Isotretinoin is a medication. It is also known as Accutane. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Isotretinoin is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Isotretinoin, it is typically taken with a meal, it is usually taken with food, and its approximate half-life is 10 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Isotretinoin carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Isotretinoin comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Isotretinoin is usually taken with a meal, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 10 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Isotretinoin with no sign-up.
There is no single answer for Isotretinoin plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Isotretinoin with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 10 hours, once-daily dosing is the usual pattern for Isotretinoin. It is typically taken with a meal. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 10 hours, a single missed dose of Isotretinoin usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Isotretinoin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Isotretinoin?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies(opens PubMed in a new tab)Dermatol Ther · 2021 · PMID 33085149 · https://pubmed.ncbi.nlm.nih.gov/33085149/
- 2.Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.(opens PubMed in a new tab)Journal of the American Academy of Dermatology · 1982 · PMID 6461675 · https://pubmed.ncbi.nlm.nih.gov/6461675/
- 3.Oral Isotretinoin and Its Uses in Dermatology: A Review(opens PubMed in a new tab)Drug Des Devel Ther · 2023 · PMID 37649956 · https://pubmed.ncbi.nlm.nih.gov/37649956/
- 4.Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment(opens PubMed in a new tab)Cells · 2023 · PMID 37998335 · https://pubmed.ncbi.nlm.nih.gov/37998335/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 5282379(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/5282379
Verify at
Publisher search links for Isotretinoin. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Isotretinoin?
Plain-text summary, safe to quote verbatim:
Isotretinoin is an oral retinoid medication primarily used for severe, recalcitrant nodular acne that has not responded to other treatments, including oral antibiotics. It is typically taken with a meal. The reported plasma half-life is about 10 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/isotretinoin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Isotretinoin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/isotretinoin
What compounds are similar to Isotretinoin?
Others in the medication category or studied for the same goals.